Senior insider sale
General Counsel at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$463.8K
9.69K shares
What this filing means
WAHL BRYAN plans to sell 9.69K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $463.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/20/2025ACC: 0001959173-25-002221
Officer· General Counsel
Since Jan 2021
9.69K
Shares to sell
$463.8K
Approx. market value
3.08K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/19/2025
3.08KTotal acquired3.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/19/2025 | Restricted Stock Vesting Compensation | 3.08K | — |
| Total | 3.08K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.26K
Market value
$154.6K
3/19/2025
—Completed
Units to sell
3.34K
Market value
$154.6K
3/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.08K
Market value
$154.6K
3/20/2025
Total
Units
9.69K
Value
$463.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/19/2025 | 3.26K | $154.6K | — | Completed |
3/18/2025 | 3.34K | $154.6K | — | Completed |
| Planned — Approximate Date | ||||
3/20/2025 | 3.08K | $154.6K | NASDAQ | Planned |
| Total | 9.69K | $463.8K | ||